Our findings suggest that in bladder cancer, JNK2 promotes p53 stability and downstream apoptosis signaling through phosphorylation of p53 at Thr81 site rather than at Ser6 site. The gene discussed is MAPK9; the disease is urinary bladder carcinoma.